These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 30175599

  • 1. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
    Lewis TC, Aberle C, Altshuler D, Piper GL, Papadopoulos J.
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
    [Abstract] [Full Text] [Related]

  • 2. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S, Malik AH, Bandyopadhyay D, Gupta R, Goel A, Briasoulis A, Fonarow GC, Lanier GM, Naidu SS.
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [Abstract] [Full Text] [Related]

  • 3. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
    Di Santo P, Mathew R, Jung RG, Simard T, Skanes S, Mao B, Ramirez FD, Marbach JA, Abdel-Razek O, Motazedian P, Parlow S, Boczar KE, D'Egidio G, Hawken S, Bernick J, Wells GA, Dick A, So DY, Glover C, Russo JJ, McGuinty C, Hibbert B, CAPITAL DOREMI investigators.
    Crit Care; 2021 Aug 10; 25(1):289. PubMed ID: 34376218
    [Abstract] [Full Text] [Related]

  • 4. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le May MR, Russo JJ, Hibbert B.
    N Engl J Med; 2021 Aug 05; 385(6):516-525. PubMed ID: 34347952
    [Abstract] [Full Text] [Related]

  • 5. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A, Schmelzle T, Simon R.
    Z Kardiol; 1996 Nov 05; 85(11):839-46. PubMed ID: 9064946
    [Abstract] [Full Text] [Related]

  • 6. Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
    Jung RG, Di Santo P, Mathew R, Abdel-Razek O, Parlow S, Simard T, Marbach JA, Gillmore T, Mao B, Bernick J, Theriault-Lauzier P, Fu A, Lau L, Motazedian P, Russo JJ, Labinaz M, Hibbert B.
    J Am Heart Assoc; 2021 Nov 02; 10(21):e021570. PubMed ID: 34713704
    [Abstract] [Full Text] [Related]

  • 7. Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation.
    Sakai M, Suzuki T, Tomita K, Yamashita S, Palikhe S, Hattori K, Yoshimura N, Matsuda N, Hattori Y.
    Am J Physiol Heart Circ Physiol; 2017 Jun 01; 312(6):H1224-H1237. PubMed ID: 28455289
    [Abstract] [Full Text] [Related]

  • 8. The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
    Parlow S, Di Santo P, Mathew R, Jung RG, Simard T, Gillmore T, Mao B, Abdel-Razek O, Ramirez FD, Marbach JA, Dick A, Glover C, Russo JJ, Froeschl M, Labinaz M, Fernando SM, Hibbert B, CAPITAL DOREMI investigators.
    Eur Heart J Acute Cardiovasc Care; 2021 Oct 01; 10(7):712-720. PubMed ID: 34382063
    [Abstract] [Full Text] [Related]

  • 9. Milrinone vs Dobutamine for the Management of Cardiogenic Shock: Implications of Renal Function and Injury.
    Di Santo P, Dehghan K, Mao B, Jung RG, Fadare D, Paydar J, Parlow S, Motazedian P, Prosperi-Porta G, Abdel-Razek O, Joseph J, Goh CY, Chung K, Mulloy A, Ramirez FD, Simard T, Hibbert B, Mathew R, Russo JJ.
    JACC Adv; 2023 Jul 01; 2(5):100393. PubMed ID: 38938997
    [Abstract] [Full Text] [Related]

  • 10. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K, Mathew R.
    Curr Opin Crit Care; 2022 Aug 01; 28(4):419-425. PubMed ID: 35792520
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Milrinone, dobutamine or epinephrine use in asphyxiated newborn pigs resuscitated with 100% oxygen.
    Joynt C, Bigam DL, Charrois G, Jewell LD, Korbutt G, Cheung PY.
    Intensive Care Med; 2010 Jun 01; 36(6):1058-66. PubMed ID: 20221750
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of dobutamine and milrinone on hemodynamic parameters and oxygen supply in patients undergoing cardiac surgery with low cardiac output after anesthetic induction.
    Carmona MJ, Martins LM, Vane MF, Longo BA, Paredes LS, Malbouisson LM.
    Rev Bras Anestesiol; 2010 Jun 01; 60(3):237-46. PubMed ID: 20682156
    [Abstract] [Full Text] [Related]

  • 15. Effects of a twenty-four-hour milrinone infusion in patients with severe heart failure and cardiogenic shock as a function of the hemodynamic initial condition.
    Klocke RK, Mager G, Kux A, Höpp HW, Hilger HH.
    Am Heart J; 1991 Jun 01; 121(6 Pt 2):1965-73. PubMed ID: 2035428
    [Abstract] [Full Text] [Related]

  • 16. Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
    Liao X, Qian L, Zhang S, Chen X, Lei J.
    J Healthc Eng; 2020 Jun 01; 2020():8862256. PubMed ID: 32802302
    [Abstract] [Full Text] [Related]

  • 17. Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.
    Mody BP, Khan MH, Zaid S, Ahn C, Lloji A, Aronow WS, Gupta CA, Levine A, Gass AL, Cooper HA, Lanier GM.
    Am J Ther; 2020 Oct 01; 28(6):e621-e630. PubMed ID: 33021537
    [Abstract] [Full Text] [Related]

  • 18. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
    Levy B, Buzon J, Kimmoun A.
    Curr Opin Crit Care; 2019 Aug 01; 25(4):384-390. PubMed ID: 31166204
    [Abstract] [Full Text] [Related]

  • 19. Dopamine may preserve the myocardial oxygen balance better than dobutamine when administered with milrinone.
    Takamatsu I, Karasawa F, Okuda T.
    Can J Anaesth; 2002 Nov 01; 49(9):968-72. PubMed ID: 12419727
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery.
    Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A, European Milrinone Multicenter Trial Group.
    J Cardiothorac Vasc Anesth; 2001 Jun 01; 15(3):306-15. PubMed ID: 11426360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.